---
title: "Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Ma... — FDA record D-0205-2024 | Is It on Recall"
description: "CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product."
url: https://isitonrecall.com/recall/fda-drug-d-0205-2024-sertraline-tablets-usp-100-mg-30-tablets-per-bottle-distributed-by-wal-mart-bentonville-ar-72716-man/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured ... — FDA record D-0205-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Dec 11, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54
- **Reason**: CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
- **Classification**: Class II
- **Recalling firm**: Legacy Pharmaceutical Packaging LLC
- **Quantity**: 161,664 bottles
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0205-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0205-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot #: 222033, exp. date 08/31/2024 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

CA and AR

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Arkansas](https://isitonrecall.com/state/arkansas/)
- [California](https://isitonrecall.com/state/california/)

## Dates in the source

- **Report date**: Jan 3, 2024
- **Recall initiation date**: Dec 11, 2023
- **Center classification date**: Dec 26, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0205-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Sertraline records](https://isitonrecall.com/drug/sertraline/) [Medications records](https://isitonrecall.com/category/medications/) [Legacy Pharmaceutical Packaging LLC records](https://isitonrecall.com/brand/legacy-pharmaceutical-packaging-llc/)